P130
12-month real-world outcomes of switching to aflibercept 8 mg in suboptimal responders with neovascular Age-Related Macular Degeneration (nARMD)
Georgios Papadakis, Riyaa Sahare, Hamza Mohammed Sultan, Ian De Silva, Rossella Anzidei, Ikenna Ahuche, Urom Chukwunonso, Somain Verma, Vasileios Konidaris
1Medical Retina, Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester UK, 3University of Leicester, Leicester, England, UK, 2Ophthalmology, University Hospitals of Leicester NHS Trust, Leiceste...
Poster Presenter: Georgios Papadakis